1. Cell Cycle/DNA Damage Stem Cell/Wnt Epigenetics
  2. Casein Kinase HDAC
  3. IOR-160

IOR-160 是 casein kinase 2 (CK2) 和 HDAC 双重抑制剂。IOR-160 对 CK2 表现出高选择性 (IC50 =1.7 nM),并且对 HDAC (HDAC 1、2、3 和 6,IC50 分别为 3.3 nM、24.0 nM、3.9 nM、13.0 nM,HDAC8 活性低) 具有广泛的抑制活性。IOR-160 通过抑制 AKT 磷酸化和乙酰化 α-微管蛋白的增加调节关键的细胞信号通路。IOR-160 通过双重 CK2/HDAC 抑制肿瘤生长并降低了肿瘤负荷。IOR-160 可用于三阴性乳腺癌研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

IOR-160

IOR-160 Chemical Structure

CAS No. : 2421119-78-8

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

IOR-160 is a dual inhibitor of casein kinase 2 (CK2) and HDACs. IOR-160 exhibits high selectivity for CK2 (IC50 = 1.7 nM) and broad inhibitory activity against HDAC (HDAC 1, 2, 3, and 6 with IC50s of 3.3 nM, 24.0 nM, 3.9 nM, and 13.0 nM, respectively, with low activity for HDAC8). IOR-160 modulates key cellular signaling pathways by inhibiting AKT phosphorylation and increasing acetylated α-tubulin. IOR-160 inhibits tumor growth and reduces tumor burden through dual CK2/HDAC inhibition. IOR-160 is indicated for use in triple-negative breast cancer research[1].

IC50 & Target[1]

CK2

1.7 nM (IC50)

HDAC1

3.3 nM (IC50)

HDAC2

24 nM (IC50)

HDAC3

3.9 nM (IC50)

HDAC6

13 nM (IC50)

体外研究
(In Vitro)

IOR-160 (0.5 μM) 对 CK2 和 HIPK2 表现出较高的抑制作用,残留活性分别为 -6% 和 7%,而对 DYRK1A、CLK2、Pim-1、Mnk2、DRAK1 和 TrkA 表现出中等至低度抑制作用 (从 18% 到 65%)[1]
IOR-160对 HDAC8 的抑制作用较弱,IC50 为 2200 nM[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

IOR-160 (1.0 mg 溶于 100 μL PBS,肿瘤内注射,每周三次,共 26 天) 通过双重 CK2/HDAC 抑制来减少携带 MDA-MB-231 细胞的非肥胖糖尿病 (NOD) scid γ 小鼠的肿瘤生长[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: MDA-MB-231 cells (3 × 106) xenograft NOD scid gamma mice (8-week-old) Model[1]
Dosage: 1.0 mg in 100 μL of PBS
Administration: injected intratumorally, three times a week, 26 days
Result: Reduced tumor growth.
Reduced pAKT levels and increased acetylated α-tubulin.
分子量

510.46

Formula

C23H25F3N4O6

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
IOR-160
目录号:
HY-176561
需求量: